Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia
Open Access
- 20 October 2003
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 18 (5) , 616-620
- https://doi.org/10.1002/jmri.10396
Abstract
Purpose To assess interscanner reproducibility of tissue iron measurements in patients with thalassemia using gradient echo T2* measurements on two different MRI scanners. Materials and Methods Twenty-five patients with thalassemia major had liver and myocardial T2* assessment using a Picker Edge 1.5T Scanner and a Siemens Sonata 1.5T scanner, with similar gradient echo sequences. In a subset of 13 patients, two scans on the Siemens scanner were performed to assess interstudy reproducibility. Results There was a highly significant, linear correlation between T2* values obtained for both the heart (r = 0.95) and the liver (r = 0.99) between scanners. The mean difference, coefficient of variability, and 95% confidence intervals between scanners were 0.8 msec, 9.4% and –5.0 to 6.7 msec for the heart; and 0.9 msec, 7.9% and –2.0 to 3.9 msec for the liver. The interstudy mean difference and coefficient of variability on the Siemens scanner was 0.3 msec and 4.8% (r = 0.99) for the heart, and 0.04 msec and 1.9% (r = 0.99) for the liver. Conclusion The T2* technique for measuring tissue iron is reproducible between the two manufacturers' scanners. This suggests that the widespread implementation of the technique is possible for clinical assessment of myocardial iron loading in thalassemia. J. Magn. Reson. Imaging 2003;18:616–620.Keywords
This publication has 12 references indexed in Scilit:
- Breath-hold FLASH and FISP Cardiovascular MR Imaging: Left Ventricular Volume Differences and ReproducibilityRadiology, 2002
- Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overloadEuropean Heart Journal, 2001
- Reduction in Sample Size for Studies of Remodeling in Heart Failure by the Use of Cardiovascular Magnetic ResonanceJournal of Cardiovascular Magnetic Resonance, 2000
- Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia RegisterThe Lancet, 2000
- Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemiaBlood, 2000
- Survival in Medically Treated Patients with Homozygous β-ThalassemiaNew England Journal of Medicine, 1994
- Regression of Cardiac Insufficiency After Ambulatory Intravenous Deferoxamine in Thalassemia MajorChest, 1993
- High Incidence of Cardiomyopathy in Beta-Thalassaemia Patients Receiving Regular Transfusion and Iron Chelation: Reversal by Intensified ChelationActa Haematologica, 1990
- SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJORPublished by Elsevier ,1989
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986